Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
WCHRI Study Title Data Management Plan Study: Version: Date: Study Details Study Title: Investigator: Code: Document History Version Date Reason For Change 1 dd mmm yyyy Initial draft Introduction This document defines the data management approach for the named study. Specifically it defines data sources, data handling practice and relevant additional documentation. Document Control This document is to be authorized by xxxx. The study sponsor (sponsor initiated studies) or Principle Investigator (investigator initiated studies) should also review and authorize the production version and any subsequent modifications. Following authorization a read-only ‘controlled’ copy will be created and the document will be allocated a version number. Subsequent changes will be authorized (see above) and the version number incremented. Each authorized version will be retained on file for audit purposes. Distribution Each authorized version is to be circulated to the following individuals who will make it available to staff as required. John Smith – Edmonton Fred Bloggs - Calgary Study Overview [Overview of study taken from Protocol, ethics application or other document as appropriate. Detailed descriptions of Clinical Data Management (CDM) tasks will follow in a later section.] Study Title [The study title.] Outline Description [Brief overview of the study.] Primary Efficacy Variables [Details of the primary efficacy variables. This is required so that appropriate data management focus can be applied to this critical data.] Secondary Efficacy Variables [Details of the secondary efficacy variables.] Page 1 of 6 WCHRI Study Title Data Management Plan Study: Version: Date: Safety Data [Details what data constitutes the safety data (if any) for the study, (Normally this would be the adverse events and lab data, however some studies may include additional safety data).] Definition of Analysis Populations [Under some circumstances these definitions may be required to focus data management activity, for instance an interim analysis involving certain sub sets of the study population.] Patient Numbers [Details the number of patients required in each group treatment/placebo/enrolled/randomized/completed as appropriate] Study Timelines [Details of first patient first visit, last patient last visit, scheduled visit intervals, interim analysis, database lock, final delivery, etc.] Ethics Status [Is the study interventional or observational? Is this a drug/device trial? Is the use of the drug/device within its approval? Trials of a medication or device that are outside the scope of its approval require CTA submission to Health Canada] [Is ethics approval required and has it been obtained? Typically ethics approval is required for the collection of subject related data. Note that where the subjects of the study are practising medical personnel ethics approval may still be required] Data Sources [Detail all sources of data – both paper and electronic] Standard Operating Procedures Data management work performed by xxxx will be undertaken using the current version of their SOPs. Scope of Work [This section is an overview of the primary tasks performed by data management and all tasks on which data management depends. Each sub-section should include a high level overview of the task and include responsibilities (site / Global / Sponsor) and interfaces.] Data Collection Mode [EDC, paper, or a combination. For a combination which sites/regions are using EDC and which are not] CRF Design [Who is designing the CRFs is CRIC input required?] Data Collection System [What systems are to be used to collect the data] Page 2 of 6 WCHRI Study Title Data Management Plan Study: Version: Date: Randomization [Describe how the study will be randomized/blinded and any applicable code break procedures] Study Monitoring [Paper CRFS] Monitoring will be performed by xxxxI / Sponsor / other personnel. Monitored CRFs will be torn down and returned to xxxx for data entry. [EDC] Electronic CRFs (OpenClinica, REDCap, etc) will be monitored electronically for accuracy (source document verification), adherence to the protocol and GCP conformance. This will be done by xxxx / sponsor / other staff. Additional data validations will be performed by xxxx as detailed below. Document Tracking [For documents received directly from investigational staff] CRFs and other documents required for data entry should be delivered to xxxx accompanied by a CRF Transmittal Form. This will detail the documents in the delivery. xxxx personnel will reconcile the transmittal form against the delivered documents. Any discrepancies will be noted on the transmittal form, which will be returned to the PI by way of receipt. [For documents stored within the xxxx filing area] When required for data entry CRFs and other required documents will be collected from the xxxx filing area. Removal of the documents will be logged on the document tracking sheet. [Where CRFs are photocopied] On receipt the original documents will be photocopied and the originals filed. Data Entry [Paper CRF] CRFs will be subject to single/double data entry according to current SOPs. [Data entry from photocopies] Data entry from the photocopied forms will proceed in a timely manner in the approximate order in which the forms are received. As data entry proceeds the working copies will be dated and initialled by the individual performing the entry. Any self evident corrections or data interpretations made by data entry staff will be indicated on the working copy. If any questions arise that cannot be resolved at the time of entry then a discrepancy will be recorded for resolution at a later date. [Where CRFs are NOT photocopied] Data entry will proceed from the original forms in a timely manner in the approximate order in which the forms are received. As data entry proceeds the forms will be discretely dated and initialled by the individual performing the entry taking care not to obscure any text on the forms. Any self evident corrections or data interpretations made by data entry staff will be noted in the data handling log. If any questions arise that cannot be resolved at the time of entry then a discrepancy will be recorded in the database for resolution at a later date. Page 3 of 6 WCHRI Study Title Data Management Plan Study: Version: Date: [EDC] The sites will complete electronic CRFs contained within the data collection system based on the contents of the patient records and other data sources. Data Handling Data handling practices for this study are documented in the study’s data handling manual. This document will be updated throughout the study as practices are refined and as new situations arise. Specifically this document covers issues such as data handling conventions, self evident corrections, data query practice and will also serve to log data handling exceptions. Data Quality The approach to data quality is based on key points contained within ICH GCP. These are: Complete Minimal missing values Accurate Database values match original observation Precise Units and measurability clearly understood Timely Minimal time between observation and recording Verifiable Independent assessment or monitoring Traceable Actions taken are logged The above points will be ensured as follows: Data Validation and Queries [Overview of data validation and query process. Should summarize relationship between data management / monitors / site / sponsor for query processing.] [EDC] Electronic data collection forms will be programmed with online validation checks (also known as edit checks). Based on an understanding of the data collection forms these checks will: Alert data entry users to missing data Check that numeric variables and dates are within reasonable ranges Check for consistency within the data Entered data will be subject to visual and electronic validation by data management staff according to an approved data validation plan. Issues that arise will be notified to the sites as queries, for resolution. [Paper CRFs] Such notification may be by any practical means including fax, email or 3-part query forms. Notification may be direct to the site or via the monitor. [EDC] Data issues will be entered into the data capture system in the form of queries/discrepancies. Sites will respond to the queries, directly in the data collection system. Query responses will be reviewed by data management staff and closed once the issue has been resolved. [REDCap] Authorized staff will review data quality using REDCap’s Data Quality module. Any identified issues will either be corrected or documented in the study data handling manual. Page 4 of 6 WCHRI Study Title Data Management Plan Study: Version: Date: Source Document Verification The above procedures only partially address the issue of transcription errors arising during form completion, some of which will be caught by online data validation. It is strongly recommended that procedures are implemented within the research clinic in order to identify and correct transcription errors. An example of such a procedure is an ongoing, systematic review of source documents (patient chart) for a randomly selected sample of subjects. Data Quality Audit At intervals throughout the study a subset of entered data will be compared with the original data collection forms. The number of compared forms and error counts will be recorded in order to measure the percentage data entry error rate. These audits will be conducted using random samples as follows: 10 of the first 100 subjects 100 of the first 1,000 subjects Every subsequent 1,000 subjects as follows: The error rate for study data will be maintained below 0.1% (one in 1,000). If the error rate from the preceding sample was above these limits then the sample will be 200 subjects. If the preceding error rate was within these limits then the sample size will be 50 subjects. If error rates remain high for three consecutive samples the team will need to consider alternative remedies in order to bring the error rate within acceptable limits. Serious Adverse Events [Interventional studies only] Overview of SAE handling, including relationship between site / sponsor / monitor and CRIC regarding SAE handling.] Serious adverse events (SAEs) are to be reported to the sponsor (or PI for investigator initiated studies) and ethics board, by the sites, as defined in the study protocol. Periodically the sponsor (or PI) will forward copies of SAE reports to the data management team for reconciliation with the CRF data. Data Coding [Is data coding required,(for example adverse event coding). If so what data and which dictionaries MedDRA? WHODDE?] Data Extract and Delivery [Define how data is to be extracted and delivered] [REDCap] Data can be exported by authorized users using REDCap’s data export module. Archiving and Destruction [Amend as appropriate] After study completion all study materials will be returned to the Principle Investigator / Sponsor for archiving. Electronic data will be retained in CRIC secure systems until such time as these systems are decommissioned. Page 5 of 6 WCHRI Study Title Data Management Plan Study: Version: Date: Tasks and Responsibilities These are summarized in the following table: Task Responsibility Notes CRF design Database configuration Database documentation Database acceptance testing Monitoring Document flow and tracking Data entry Data validation Discrepancy resolution Data extract Analysis database creation Study materials archiving Data archiving Authorization: Author: (Signature) Date: Authorised by: (PI or Sponsor) Date: Page 6 of 6